Molecular Structure Suggests How a Gene Can "Jump"
Article originally published in July, 2000
Article in
Science shows how an enzyme binds to DNA; the complex may be a
model that speeds the search for HIV inhibitors.
Nearly fifty years after a landmark paper proposed the existence of what
later came to be called jumping genes, scientists are getting their first
clear snapshot of one caught in midleap.
In the July 7 issue of the journal Science, a University of
Wisconsin-Madison team describes the 3-dimensional, atomic structure of an
enzyme that allows a transposable genetic element in a bacterium to "jump"
from one part of DNA to another.
The structure of this complex - featured on the journal's cover - gives
researchers a new framework for understanding how transposable elements
operate, according to the paper's lead authors Ivan Rayment and Bill
Reznikoff. The finding also may accelerate the search for new drugs to
inhibit AIDS.
"Transposable elements have the potential to remodel genomes and to
facilitate the movement of genetic information, such as antibiotic
resistance," says Reznikoff, a molecular geneticist.
The transposition of DNA is central to genetics and evolution. Transposable
elements are an important source of the mutations on which natural
selection operates. Scientists estimate that transposable elements make up
as much as 30 percent of the human genome, for example.
In Science, the Wisconsin team describes the 3-dimensional
structure of the Escherischia coli Tn5 transposase bound to the Tn5
transposable element. "Our discovery is an important step in understanding
the structural basis for transposition," says Rayment, a crystallographer
and molecular biologist.
The team's findings have implications for AIDS researchers because
the human immunodeficiency virus-1 (HIV-1) uses a process similar to DNA
transposition to insert itself into human DNA.
"Just as enzymes called transposases make transposition possible,
enzymes called integrases catalyze similar events in retroviruses,
including HIV-1," Rayment says. "Researchers have now studied the catalytic
core of five different transposases and integrases, and they show
remarkable similarity. Therefore, a clear image of one of them provides
greater understanding of all similar ones."
To control AIDS, researchers in the pharmaceutical industry are
screening compounds that can inhibit HIV-1 integrase, according to Rayment
and Reznikoff. Because HIV-1 integrase and Tn5 transposase have similar
structures, the Wisconsin scientists believe they now have a model system
that can help scientists identify or design compounds effective in
controlling HIV-1.
The paper's co-authors include Douglas Davies and Igor Goryshin.
Davies worked with Rayment to develop the DNA-enzyme crystals and analyze
them using X-ray crystallography. Goryshin, a molecular biologist, worked
with Reznikoff in developing, isolating and purifying the transposase. The
research team - all with the Department of Biochemistry in the College of
Agricultural and Life Sciences - worked together to solve the structure of
the complex.
In 1951, geneticist Barbara McClintock proposed "controlling elements" to
explain genetic patterns she observed in corn. Many geneticists were slow
to appreciate the importance McClintock's discovery, for which she received
a Nobel Prize in 1983. However, researchers have since made remarkable
progress in understanding the molecular nature transposable elements.
Past studies of the structure of the enzymes that trigger transposition
have focused on the core region that cuts the element from DNA, Rayment
says. Researchers have not known what the entire enzyme looks like or how
it binds to and interacts with DNA. Capturing the 3-dimensional structure
of the complex, allowed the UW-Madison team to present a much clearer view
of how the enzyme and DNA interact at the molecular level.
Prior to transposition, one copy of Tn5 transposase binds to a
specific region at one end of the transposon and a second copy binds to an
identical region at the opposite end. Neither enzyme can cut DNA at the
site to which it binds. When events produce a loop in the Tn5 transposable
element the two enzymes at the ends come together. The Wisconsin research
shows how the architecture of the resulting complex positions each enzyme
so it can then cleave the opposite end of the transposable element DNA from
its initial binding site. The Tn5-enzyme complex can then move freely
before it inserts itself into a new location.
The research was supported by: state funding to the UW-Madison College of
Agricultural and Life Sciences, and grants from the National Institute of
General Medical Sciences; National Institute of Arthritis and
Musculoskeletal and Skin Diseases; the U.S. Department of Energy; and a
Vilas Associates Award from the UW-Madison.
***
Writer: George Gallepp
Contact: Ivan Rayment (608) 262-0437; reznikoff@biochem.wisc.edu
|